Skip to Content
  1. All products
  2. Fitness & Performance
  3. CJC-1295 No DAC / Ipamorelin
  4. Fitness & Performance
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
CJC-1295 No DAC / Ipamorelin

CJC-1295 No DAC / Ipamorelin

Blend · Subcutaneous Refrigerate after reconstitution (2-8°C) 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 56.00 $ 56.00

Format
⚗ blend
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Growth hormone release, muscle growth, recovery improvement, fat loss, anti-aging

La mezcla CJC-1295/Ipamorelin combina un análogo GHRH con un GHRP para una estimulación potente y natural de la hormona del crecimiento. Esta mezcla promueve el crecimiento muscular, mejora de la recuperación, pérdida de grasa y efectos antienvejecimiento.

Clinical Indications
GH-axis optimization protocolsRecovery and lean-mass support plansSleep-linked anabolic pathway support
Recommended Stacking Protocols
✓
Growth Hormone Peptides Base
Core growth hormone peptides support for consistent outcomes.
✓
Adjunct Support
Complementary growth hormone peptides pathway when indicated.
Blend Components
Component Amount (mg)
CJC-1295 No DAC 5
Ipamorelin 5

Mechanism of Action - Growth Hormone Peptides Pathway

Targeted Signaling
Supports protocol objectives for CJC-1295 No DAC / Ipamorelin.
Clinical Modulation
Allows dose and schedule adjustments by response.
Outcome Tracking
Pairs with clinician monitoring for iterative optimization.
Starting Dose
Low initial dose
Initiation phase for tolerance and baseline response.
Titration
Escalate by protocol
Maintenance Range
Maintain physician-directed target
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis objetivo:100mcg each (CJC + Ipa)

Frecuencia:1-3 veces al día (mañana/antes del entrenamiento/antes de acostarse)

Ciclo:8-12 semanas + 2-4 semanas de descanso

Period Dose Phase Clinical Notes
Weeks 1-2 Initial phase initiation Begin conservatively and monitor tolerance.
Weeks 3-6 Escalation phase escalation Increase per protocol if tolerated.
Week 7+ Maintenance phase maintenance Maintain target dose and reassess monthly.
Preparation Protocol
  1. Vía: Subcutánea (abdomen o zona de michelines).
  2. Utilice una jeringa de insulina de 0,5 ml (100 unidades = 1 ml).
  3. Momento: Con el estómago vacío (mejor 30 minutos antes de la comida o 90 minutos después de comer).
  4. Almacenamiento: Refrigerar después de la reconstitución (2-8°C).
1
Inspect vial
Confirm vial integrity, lot, and expiration before use.
2
Aseptic reconstitution
Disinfect stopper and add bacteriostatic water slowly.
3
Gentle dissolution
Swirl gently until the solution is clear and homogeneous.
4
Prepare dose
Draw dose according to reconstitution conversion guidance.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 10 mg
BW: 2.5 mL
Concentration: 4mg/mL total (2mg/mL each)
Dose Units to Draw Volume (mL) Approx. Supply
100mcg each 5 units 0.05mL 100 injections per vial
50mcg each 2.5 units 0.025mL 200 injections per vial

Total Peptide: 20 mg
BW: 3 mL
Concentration: 6.67mg/mL total (3.33mg/mL each)
Dose Units to Draw Volume (mL) Approx. Supply
100mcg each 3 units 0.03mL 200 injections per vial
50mcg each 1.5 units 0.015mL 400 injections per vial

Total Peptide: 18 mg
BW: 5 mL
Concentration: 3.6mg/mL total (2.4mg/mL CJC + 1.2mg/mL Ipa)
Dose Units to Draw Volume (mL) Approx. Supply
100mcg CJC + 50mcg Ipa 4.2 units 0.042mL 180 injections per vial
50mcg CJC + 25mcg Ipa 2.1 units 0.021mL 360 injections per vial
Identity
  • Product Name: CJC-1295 No DAC / Ipamorelin
  • Product Type: Blend | Subcutaneous Injection
  • Strength Options: 5/5 mg
  • Components: CJC-1295 No DAC + Ipamorelin
  • Available Strengths: 5mg/5mg, 10mg/10mg, 12mg/6mg
Quality & Purity
  • Purity: >= 99%
  • Sterility: Aseptic handling required
  • Purity: 99%+
Storage & Handling
  • Storage: 2-8 C refrigerated
  • Handling: Avoid heat, shaking, and direct light
  • Storage: Refrigerate after reconstitution (2-8°C)

Timing: Empty stomach (best 30 min before food or 90 min after eating)

Storage: Refrigerate after reconstitution (2-8°C)

Frequency: 1-3xdaily(Morning/Pre-Workout/BeforeBed) 1-3xdailyas above 1-2xdailyonempty stomach(morning+pre-bed)

Cycle: 8-12 weeks on → 2-4 weeks off

Injection Sites: Route-Subcutaneous(abdomen or love-handle area)